Production and characterisation of a neutralising chimeric antibody against botulinum neurotoxin A

PloS One
Julie PrigentStéphanie Simon

Abstract

Botulinum neurotoxins, produced by Clostridium botulinum bacteria, are the causative agent of botulism. This disease only affects a few hundred people each year, thus ranking it among the orphan diseases. However, botulinum toxin type A (BoNT/A) is the most potent toxin known to man. Due to their potency and ease of production, these toxins were classified by the Centers for Disease Control and Prevention (CDC) as Category A biothreat agents. For several biothreat agents, like BoNT/A, passive immunotherapy remains the only possible effective treatment allowing in vivo neutralization, despite possible major side effects. Recently, several mouse monoclonal antibodies directed against a recombinant fragment of BoNT/A were produced in our laboratory and most efficiently neutralised the neurotoxin. In the present work, the most powerful one, TA12, was selected for chimerisation. The variable regions of this antibody were thus cloned and fused with the constant counterparts of human IgG1 (kappa light and gamma 1 heavy chains). Chimeric antibody production was evaluated in mammalian myeloma cells (SP2/0-Ag14) and insect cells (Sf9). After purifying the recombinant antibody by affinity chromatography, the biochemical properties of chim...Continue Reading

References

May 1, 1984·The American Journal of Medicine·C O TacketP A Blake
Oct 1, 1980·The American Journal of Medicine·R E Black, R A Gunn
May 1, 1996·Infection and Immunity·K InoueK Oguma
Aug 8, 1998·Annals of Internal Medicine·R L ShapiroD L Swerdlow
Mar 7, 2001·JAMA : the Journal of the American Medical Association·Stephen S ArnonWorking Group on Civilian Biodefense
Jun 4, 2002·Nature Biotechnology·Jennifer A MaynardGeorge Georgiou
Aug 15, 2002·Proceedings of the National Academy of Sciences of the United States of America·A NowakowskiJ D Marks
Aug 21, 2003·Annales de réadaptation et de médecine physique : revue scientifique de la Société française de rééducation fonctionnelle de réadaptation et de médecine physique·B Poulain, Y Humeau
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·Lance L Simpson
Apr 15, 2004·Analytical Biochemistry·Andrew W DrakeScott L Klakamp
Sep 11, 2004·Protein Expression and Purification·Mark C MowryAnu Subramanian
Sep 17, 2004·Nature Reviews. Microbiology·Arturo CasadevallLiise-anne Pirofski
Aug 1, 1949·The Journal of Physiology·A S V BURGENL J ZATMAN
Aug 9, 2005·Applied and Environmental Microbiology·Harry B HinesErnst E Brueggemann
Sep 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J Sobel
Oct 13, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Sophia HoberMartin Linhult
Jan 9, 2007·New Solutions : a Journal of Environmental and Occupational Health Policy : NS·Council for State and Territorial Epidemiologists
Dec 21, 2007·Journal of Immunological Methods·Hervé VollandChristophe Créminon
Apr 5, 2008·Disaster Medicine and Public Health Preparedness·Zygmunt F DembekJanice M Rusnak
Jun 25, 2008·Toxicon : Official Journal of the International Society on Toxinology·Carrie J DonovanTom A Gill
Apr 28, 2009·Biochemical and Biophysical Research Communications·Keita MiyataTohru Ohyama
Aug 5, 2009·Infection and Immunity·Luisa W ChengJ D Marks
Aug 21, 2010·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·L-A KingH de Valk

Citations

Jan 10, 2014·The Journal of Clinical Investigation·Stylianos BournazosJeffrey V Ravetch
Sep 25, 2019·Toxins·Christine Rasetti-Escargueil, Michel R Popoff
Apr 5, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sébastien BrierMichel R Popoff

Methods Mentioned

BETA
transfection
Surface
biosensor
chip
sandwich immunoassay
glycosylation
PCR
surface plasmonic resonance
chips

Related Concepts

Related Feeds

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.